TY - JOUR AU - Vermorken, J. B. AU - Trigo, J. AU - Hitt, R. AU - Koralewski, P. AU - Diaz-Rubio, E. AU - Rolland, F. PY - 2007 DA - 2007// TI - Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.06.7447 DO - 10.1200/JCO.2006.06.7447 ID - Vermorken2007 ER - TY - JOUR AU - Langer, C. J. PY - 2008 DA - 2008// TI - Targeted therapy in head and neck cancer: state of the art 2007 and review of clinical applications JO - Cancer VL - 112 UR - https://doi.org/10.1002/cncr.23521 DO - 10.1002/cncr.23521 ID - Langer2008 ER - TY - JOUR AU - Bonner, J. A. AU - Harari, P. M. AU - Giralt, J. AU - Azarnia, N. AU - Shin, D. M. AU - Cohen, R. B. PY - 2006 DA - 2006// TI - Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMoa053422 DO - 10.1056/NEJMoa053422 ID - Bonner2006 ER - TY - JOUR AU - Vermorken, J. B. AU - Mesia, R. AU - Rivera, F. AU - Remenar, E. AU - Kawecki, A. AU - Rottey, S. PY - 2008 DA - 2008// TI - Platinum-based chemotherapy plus cetuximab in head and neck cancer JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0802656 DO - 10.1056/NEJMoa0802656 ID - Vermorken2008 ER - TY - STD TI - Trivedi S, Concha-Benavente F, Srivastava RM, Jie HB, Gibson SP, Schmitt NC, et al. Immune biomarkers of anti-EGFR monoclonal antibody therapy. Ann Oncol. Oct;41(5):678-84. ID - ref5 ER - TY - JOUR AU - Srivastava, R. M. AU - Lee, S. C. AU - Andrade Filho, P. A. AU - Lord, C. A. AU - Jie, H. B. AU - Davidson, H. C. PY - 2013 DA - 2013// TI - Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-2426 DO - 10.1158/1078-0432.CCR-12-2426 ID - Srivastava2013 ER - TY - JOUR AU - Gabrilovich, D. I. AU - Ostrand-Rosenberg, S. AU - Bronte, V. PY - 2012 DA - 2012// TI - Coordinated regulation of myeloid cells by tumours JO - Nat Rev Immunol VL - 12 UR - https://doi.org/10.1038/nri3175 DO - 10.1038/nri3175 ID - Gabrilovich2012 ER - TY - JOUR AU - Ostrand-Rosenberg, S. PY - 2010 DA - 2010// TI - Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity JO - Cancer Immunol VL - 59 UR - https://doi.org/10.1007/s00262-010-0855-8 DO - 10.1007/s00262-010-0855-8 ID - Ostrand-Rosenberg2010 ER - TY - JOUR AU - Ochando, J. C. AU - Chen, S. H. PY - 2012 DA - 2012// TI - Myeloid-derived suppressor cells in transplantation and cancer JO - Immunol Res VL - 54 UR - https://doi.org/10.1007/s12026-012-8335-1 DO - 10.1007/s12026-012-8335-1 ID - Ochando2012 ER - TY - JOUR AU - Gabitass, R. F. AU - Annels, N. E. AU - Stocken, D. D. AU - Pandha, H. A. AU - Middleton, G. W. PY - 2011 DA - 2011// TI - Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13 JO - Cancer Immunol VL - 60 UR - https://doi.org/10.1007/s00262-011-1028-0 DO - 10.1007/s00262-011-1028-0 ID - Gabitass2011 ER - TY - JOUR AU - Qian, B. Z. AU - Pollard, J. W. PY - 2010 DA - 2010// TI - Macrophage diversity enhances tumor progression and metastasis JO - Cell VL - 141 UR - https://doi.org/10.1016/j.cell.2010.03.014 DO - 10.1016/j.cell.2010.03.014 ID - Qian2010 ER - TY - JOUR AU - Mantovani, A. AU - Sica, A. PY - 2010 DA - 2010// TI - Macrophages, innate immunity and cancer: balance, tolerance, and diversity JO - Curr Opin Immunol VL - 22 UR - https://doi.org/10.1016/j.coi.2010.01.009 DO - 10.1016/j.coi.2010.01.009 ID - Mantovani2010 ER - TY - JOUR AU - Liu, C. Y. AU - Wang, Y. M. AU - Wang, C. L. AU - Feng, P. H. AU - Ko, H. W. AU - Liu, Y. H. PY - 2010 DA - 2010// TI - Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14(−)/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer JO - J Cancer Res Clin Oncol VL - 136 UR - https://doi.org/10.1007/s00432-009-0634-0 DO - 10.1007/s00432-009-0634-0 ID - Liu2010 ER - TY - JOUR AU - Kusmartsev, S. AU - Nefedova, Y. AU - Yoder, D. AU - Gabrilovich, D. I. PY - 2004 DA - 2004// TI - Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species JO - J Immunol VL - 172 UR - https://doi.org/10.4049/jimmunol.172.2.989 DO - 10.4049/jimmunol.172.2.989 ID - Kusmartsev2004 ER - TY - JOUR AU - Cheng, P. AU - Corzo, C. A. AU - Luetteke, N. AU - Yu, B. AU - Nagaraj, S. AU - Bui, M. M. PY - 2008 DA - 2008// TI - Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein JO - J Exp Med VL - 205 UR - https://doi.org/10.1084/jem.20080132 DO - 10.1084/jem.20080132 ID - Cheng2008 ER - TY - JOUR AU - Gallina, G. AU - Dolcetti, L. AU - Serafini, P. AU - Santo, C. AU - Marigo, I. AU - Colombo, M. P. PY - 2006 DA - 2006// TI - Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells JO - J Clin Invest VL - 116 UR - https://doi.org/10.1172/JCI28828 DO - 10.1172/JCI28828 ID - Gallina2006 ER - TY - JOUR AU - Bronte, V. AU - Zanovello, P. PY - 2005 DA - 2005// TI - Regulation of immune responses by L-arginine metabolism JO - Nat Rev Immunol VL - 5 UR - https://doi.org/10.1038/nri1668 DO - 10.1038/nri1668 ID - Bronte2005 ER - TY - JOUR AU - Brandau, S. AU - Trellakis, S. AU - Bruderek, K. AU - Schmaltz, D. AU - Steller, G. AU - Elian, M. PY - 2011 DA - 2011// TI - Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties JO - J Leukoc Biol VL - 89 UR - https://doi.org/10.1189/jlb.0310162 DO - 10.1189/jlb.0310162 ID - Brandau2011 ER - TY - JOUR AU - Vasquez-Dunddel, D. AU - Pan, F. AU - Zeng, Q. AU - Gorbounov, M. AU - Albesiano, E. AU - Fu, J. PY - 2013 DA - 2013// TI - STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients JO - J Clin Invest VL - 123 UR - https://doi.org/10.1172/JCI60083 DO - 10.1172/JCI60083 ID - Vasquez-Dunddel2013 ER - TY - JOUR AU - Guilliams, M. AU - Bruhns, P. AU - Saeys, Y. AU - Hammad, H. AU - Lambrecht, B. N. PY - 2014 DA - 2014// TI - The function of Fcγ receptors in dendritic cells and macrophages JO - Nat Rev Immunol VL - 14 UR - https://doi.org/10.1038/nri3582 DO - 10.1038/nri3582 ID - Guilliams2014 ER - TY - JOUR AU - Buechler, C. AU - Ritter, M. AU - Orso, E. AU - Langmann, T. AU - Klucken, J. AU - Schmitz, G. PY - 2000 DA - 2000// TI - Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli JO - J Leukoc Biol VL - 67 ID - Buechler2000 ER - TY - JOUR AU - Kuang, D. M. AU - Peng, C. AU - Zhao, Q. AU - Wu, Y. AU - Chen, M. S. AU - Zheng, L. PY - 2010 DA - 2010// TI - Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells JO - Hepatology VL - 51 UR - https://doi.org/10.1002/hep.23291 DO - 10.1002/hep.23291 ID - Kuang2010 ER - TY - JOUR AU - Mota, G. AU - Moldovan, I. AU - Calugaru, A. AU - Hirt, M. AU - Kozma, E. AU - Galatiuc, C. PY - 2004 DA - 2004// TI - Interaction of human immunoglobulin G with CD16 on natural killer cells: ligand clearance, FcgammaRIIIA turnover and effects of metalloproteinases on FcgammaRIIIA-mediated binding, signal transduction and killing JO - Scand J Immunol VL - 59 UR - https://doi.org/10.1111/j.0300-9475.2004.01398.x DO - 10.1111/j.0300-9475.2004.01398.x ID - Mota2004 ER - TY - JOUR AU - Romee, R. AU - Foley, B. AU - Lenvik, T. AU - Wang, Y. AU - Zhang, B. AU - Ankarlo, D. PY - 2013 DA - 2013// TI - NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17) JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-04-425397 DO - 10.1182/blood-2012-04-425397 ID - Romee2013 ER - TY - JOUR AU - Murray, P. J. AU - Wynn, T. A. PY - 2011 DA - 2011// TI - Protective and pathogenic functions of macrophage subsets JO - Nat Rev Immunol VL - 11 UR - https://doi.org/10.1038/nri3073 DO - 10.1038/nri3073 ID - Murray2011 ER - TY - JOUR AU - Pander, J. AU - Heusinkveld, M. AU - Straaten, T. AU - Jordanova, E. S. AU - Baak-Pablo, R. AU - Gelderblom, H. PY - 2011 DA - 2011// TI - Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0239 DO - 10.1158/1078-0432.CCR-11-0239 ID - Pander2011 ER - TY - STD TI - Chwee Ming Lim RS, Andres M Salazar and Robert L. Ferris. TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+ head and neck cancer cells. Oncoimmunology. 2013;2:e24677. ID - ref27 ER - TY - JOUR AU - Jie, H. B. AU - Schuler, P. J. AU - Lee, S. C. AU - Srivastava, R. M. AU - Argiris, A. AU - Ferrone, S. PY - 2015 DA - 2015// TI - CTLA-4(+) regulatory T cells increased in cetuximab-treated head and neck cancer patients suppress NK cell cytotoxicity and correlate with poor prognosis JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.CAN-14-2788 DO - 10.1158/0008-5472.CAN-14-2788 ID - Jie2015 ER - TY - JOUR AU - Edin, S. AU - Wikberg, M. L. AU - Dahlin, A. M. AU - Rutegard, J. AU - Oberg, A. AU - Oldenborg, P. A. PY - 2012 DA - 2012// TI - The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0047045 DO - 10.1371/journal.pone.0047045 ID - Edin2012 ER - TY - JOUR AU - Srivastava, R. M. AU - Trivedi, S. AU - Concha-Benavente, F. AU - Hyun-Bae, J. AU - Wang, L. AU - Seethala, R. R. PY - 2015 DA - 2015// TI - STAT1-induced HLA class I upregulation enhances immunogenicity and clinical response to anti-EGFR mAb cetuximab therapy in HNC patients JO - Can Immun Res VL - 3 UR - https://doi.org/10.1158/2326-6066.CIR-15-0053 DO - 10.1158/2326-6066.CIR-15-0053 ID - Srivastava2015 ER - TY - JOUR AU - Moskowitz, H. S. AU - Gooding, W. E. AU - Thomas, S. M. AU - Freilino, M. L. AU - Gross, N. AU - Argiris, A. PY - 2012 DA - 2012// TI - Serum biomarker modulation following molecular targeting of epidermal growth factor and cyclooxygenase pathways: a pilot randomized trial in head and neck cancer JO - Oral Oncol VL - 48 UR - https://doi.org/10.1016/j.oraloncology.2012.05.015 DO - 10.1016/j.oraloncology.2012.05.015 ID - Moskowitz2012 ER -